{
  "doc_id": "Polymorphous-Low",
  "doc_filename": "Polymorphous-Low.pdf",
  "top_entities": [
    {
      "name": "adenocarcinoma",
      "mention_count": 1,
      "entity_type": "disease"
    },
    {
      "name": "Rare tumor",
      "mention_count": 1,
      "entity_type": "disease"
    },
    {
      "name": "parotid",
      "mention_count": 1,
      "entity_type": "drug"
    }
  ],
  "file_size_bytes": 2533,
  "file_size_human": "2.5 KB",
  "file_extension": ".pdf",
  "pdf_title": "(anonymous)",
  "pdf_author": "(anonymous)",
  "pdf_page_count": 1,
  "pdf_creation_date": "2026-01-07T22:25:17",
  "doi": null,
  "doi_url": null,
  "document_type_code": "MED",
  "document_type_name": "Patient Education & Advocacy",
  "document_type_group": "Patient-Centric Documentation",
  "classification_confidence": 0.25,
  "title": "Polymorphous Low-Grade Adenocarcinoma (PLGA): Clinical Overview and Diagnostic Guidelines",
  "short_description": "Clinical document describing polymorphous low-grade adenocarcinoma, a rare salivary gland tumor primarily affecting minor salivary glands in the palate.",
  "long_description": "This clinical reference document provides a comprehensive overview of polymorphous low-grade adenocarcinoma (PLGA), a rare malignant tumor of the salivary glands. The document details the anatomical distribution of major and minor salivary glands, explains that PLGA predominantly affects the minor salivary glands particularly in the palate, and outlines key clinical symptoms requiring medical attention including lumps, persistent pain, gland asymmetry, unexplained bleeding, and facial numbness or weakness. It presents demographic information showing the disease typically affects middle-aged patients (median age 57) with a slight female predominance, and emphasizes the importance of early diagnosis through biopsy confirmation for proper treatment outcomes.",
  "document_date": "2026-01-07T22:25:17",
  "document_date_source": "pdf_metadata",
  "extraction_timestamp": "2026-02-05T01:54:41.103424"
}